4 reports of this reaction
5.3% of all CAMPHOR AND MENTHOL reports
#3 most reported adverse reaction
DYSPNOEA is the #3 most commonly reported adverse reaction for CAMPHOR AND MENTHOL, manufactured by Bayer HealthCare LLC. There are 4 FDA adverse event reports linking CAMPHOR AND MENTHOL to DYSPNOEA. This represents approximately 5.3% of all 75 adverse event reports for this drug.
Patients taking CAMPHOR AND MENTHOL who experience dyspnoea should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
DYSPNOEA is moderately reported among CAMPHOR AND MENTHOL users, representing a notable but not dominant share of adverse events.
In addition to dyspnoea, the following adverse reactions have been reported for CAMPHOR AND MENTHOL:
The following drugs have also been linked to dyspnoea in FDA adverse event reports:
DYSPNOEA has been reported as an adverse event in 4 FDA reports for CAMPHOR AND MENTHOL. This does not prove causation, but indicates an association observed in post-market surveillance data.
DYSPNOEA accounts for approximately 5.3% of all adverse event reports for CAMPHOR AND MENTHOL, making it one of the most commonly reported side effect.
If you experience dyspnoea while taking CAMPHOR AND MENTHOL, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.